Batch traceability, sterility and endotoxins: separate questions
Batch traceability connects a tested sample to the material supplied. It does not expand the tests performed. Identity, purity, quantity, sterility and endotoxin results answer different questions, and a result for bulk material should not automatically be treated as a result for a later filled vial.
Follow the sample through the records
Record the order reference, product and strength, visible identifiers, laboratory sample ID and report number. Ask whether the sample was bulk material, a finished vial or a pooled set of vials, and who submitted it.
If material was filled, repacked or relabelled after testing, ask which records link those stages. ICH Q7 treats batch identification and original-certificate references as part of traceability. A shared product name is not that documentary link.
Distinguish chemical and microbial evidence
Endotoxins are associated with gram-negative bacteria and can remain after bacteria are no longer viable. Reducing microbial contamination therefore does not automatically remove endotoxins. Chemical purity is another distinct measurement.
| Evidence | Main question | Cannot replace |
|---|---|---|
| Identity / purity / quantity | What chemical material was detected and measured? | Sterility or endotoxin testing. |
| Sterility test | Was microbial growth detected under the test conditions? | A separate assessment of endotoxins. |
| Bacterial endotoxin test | What endotoxin activity was detected within the method's scope? | A sterility test or a general guarantee of suitability. |
A test result has sampling limits
A sterility test examines a sample using defined conditions. FDA guidance explains that limited sampling can miss contaminated units; a negative result should not be inflated into proof that every unit is sterile.
For an endotoxin report, check the sample description, result units, method sensitivity and whether sample interference was addressed. 'Not detected' has meaning only within the stated method and limit. Do not translate it into absolute zero.
What FSD's published policy establishes
FSD's policy states that production batches are tested. Public batch-specific COAs and batch identifiers are available for selected products, and not every vial has publicly traceable batch documentation. The library contains the reports currently published; a supplier statement about testing is not a substitute for a matching report.
FSD does not offer an endotoxin guarantee. Its voluntary refund thresholds concern eligible purity or quantity results from Janoshik or Freedom Diagnostics. These terms do not establish sterility or suitability for human or veterinary administration.
Document the gap before interpreting a result
If you cannot identify the relevant batch, state that in your laboratory record. If only a bulk report is available, describe it as a bulk report. Ask support for the available connection to your purchase before treating a result as batch-specific evidence for it.
Common questions
Does 'batch tested' mean every vial was tested?
No. Ask what units were sampled and what the sampling represents. A batch-level statement does not establish individual testing of each supplied vial.
Does high HPLC purity establish low endotoxins?
No. HPLC purity and endotoxin activity are different measurements. The relevant endotoxin test must be reported separately.
Sources & scope
These references explain analytical and research principles. They do not certify FSD BIO LABS or provide evidence about a particular FSD batch.
- ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients — FDA / ICH
Sections 11.4 and 17 describe COA contents, original report references and batch traceability. Used as a documentation benchmark; it does not establish FSD's GMP status. - Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice — FDA
Sections VII and XI distinguish endotoxin control and sterility testing and explain the limitations of sterility sampling. This is background science, not a claim of sterile manufacture by FSD. - Pyrogen and Endotoxins Testing: Questions and Answers — FDA
The currently linked March 2026 guidance covers sampling, test interference and endotoxin method suitability. No human-use limits are proposed for research materials. - Bacterial Endotoxins/Pyrogens — FDA
Historical technical background on gram-negative bacterial endotoxins and why microbial reduction does not establish endotoxin removal. Not used for current regulatory limits or testing requirements.